236 related articles for article (PubMed ID: 30242125)
1. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
2. Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.
Siddiqua A; Margittai M
J Biol Chem; 2010 Nov; 285(48):37920-6. PubMed ID: 20921227
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic and Structural Origins of the Asymmetric Barrier to Prion-like Cross-Seeding between Tau-3R and Tau-4R.
Kumar H; Udgaonkar JB
J Mol Biol; 2018 Dec; 430(24):5304-5312. PubMed ID: 30267747
[TBL] [Abstract][Full Text] [Related]
4. RNA Binds to Tau Fibrils and Sustains Template-Assisted Growth.
Dinkel PD; Holden MR; Matin N; Margittai M
Biochemistry; 2015 Aug; 54(30):4731-40. PubMed ID: 26177386
[TBL] [Abstract][Full Text] [Related]
5. Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau.
Siddiqua A; Luo Y; Meyer V; Swanson MA; Yu X; Wei G; Zheng J; Eaton GR; Ma B; Nussinov R; Eaton SS; Margittai M
J Am Chem Soc; 2012 Jun; 134(24):10271-8. PubMed ID: 22656332
[TBL] [Abstract][Full Text] [Related]
6. A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly.
Weismiller HA; Holub TJ; Krzesinski BJ; Margittai M
J Biol Chem; 2021 Sep; 297(3):101021. PubMed ID: 34339733
[TBL] [Abstract][Full Text] [Related]
7. Precision proteoform design for 4R tau isoform selective templated aggregation.
Longhini AP; DuBose A; Lobo S; Vijayan V; Bai Y; Rivera EK; Sala-Jarque J; Nikitina A; Carrettiero DC; Unger MT; Sclafani OR; Fu V; Beckett ER; Vigers M; Buée L; Landrieu I; Shell S; Shea JE; Han S; Kosik KS
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2320456121. PubMed ID: 38568974
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
[TBL] [Abstract][Full Text] [Related]
9. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease.
Kraus A; Saijo E; Metrick MA; Newell K; Sigurdson CJ; Zanusso G; Ghetti B; Caughey B
Acta Neuropathol; 2019 Apr; 137(4):585-598. PubMed ID: 30570675
[TBL] [Abstract][Full Text] [Related]
10. Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles.
Dregni AJ; Duan P; Xu H; Changolkar L; El Mammeri N; Lee VM; Hong M
Nat Commun; 2022 May; 13(1):2967. PubMed ID: 35624093
[TBL] [Abstract][Full Text] [Related]
11. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
12. MAP2 caps tau fibrils and inhibits aggregation.
Holden MR; Krzesinski BJ; Weismiller HA; Shady JR; Margittai M
J Biol Chem; 2023 Jul; 299(7):104891. PubMed ID: 37286038
[TBL] [Abstract][Full Text] [Related]
13. Variations in filament conformation dictate seeding barrier between three- and four-repeat tau.
Dinkel PD; Siddiqua A; Huynh H; Shah M; Margittai M
Biochemistry; 2011 May; 50(20):4330-6. PubMed ID: 21510682
[TBL] [Abstract][Full Text] [Related]
14. Structures of filaments from Pick's disease reveal a novel tau protein fold.
Falcon B; Zhang W; Murzin AG; Murshudov G; Garringer HJ; Vidal R; Crowther RA; Ghetti B; Scheres SHW; Goedert M
Nature; 2018 Sep; 561(7721):137-140. PubMed ID: 30158706
[TBL] [Abstract][Full Text] [Related]
15. Single mutations in tau modulate the populations of fibril conformers through seed selection.
Meyer V; Dinkel PD; Luo Y; Yu X; Wei G; Zheng J; Eaton GR; Ma B; Nussinov R; Eaton SS; Margittai M
Angew Chem Int Ed Engl; 2014 Feb; 53(6):1590-3. PubMed ID: 24453187
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
Jung HJ; Park SS; Mok JO; Lee TK; Park CS; Park SA
Exp Neurol; 2011 Apr; 228(2):232-41. PubMed ID: 21281635
[TBL] [Abstract][Full Text] [Related]
17. Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils.
Nizynski B; Nieznanska H; Dec R; Boyko S; Dzwolak W; Nieznanski K
PLoS One; 2018; 13(7):e0201182. PubMed ID: 30024984
[TBL] [Abstract][Full Text] [Related]
18. Precision Proteoform Design for 4R Tau Isoform Selective Templated Aggregation.
Longhini AP; DuBose A; Lobo S; Vijayan V; Bai Y; Rivera EK; Sala-Jarque J; Nikitina A; Carrettiero DC; Unger M; Sclafani O; Fu V; Vigers M; Buee L; Landrieu I; Shell S; Shea JE; Han S; Kosik KS
bioRxiv; 2023 Nov; ():. PubMed ID: 37693456
[TBL] [Abstract][Full Text] [Related]
19. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
[TBL] [Abstract][Full Text] [Related]
20. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
